Autor: |
Sartori, G., Priebe, V., Cascione, L., Favre‐Juilland, M., Chung, E. Y., Napoli, S., Arribas, A., Rinaldi, A., Miazza, M. Thome, Bertoni, F. |
Předmět: |
|
Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p250-251, 2p |
Abstrakt: |
B Introduction: b We have previously shown that the two ETS transcription factors ETS1 and FLI1, co-mapped in the 11q24.3 region, are recurrently gained in up to 25% of diffuse large B cell lymphomas (DLBCL), and largely co-regulate a series of genes involved in B cell signaling, differentiation and cell cycle (Bonetti et al., 2013; Priebe et al., 2020; Sartori et al., 2021). We focused on the novel ETS1 interactor DDX21, an RNA helicase also regulated by FLI1 (Sartori et al., 2021). [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|